OUR ADVANTAGE

Clinical trials require strict adherence to protocol, extensive documentation, complete accuracy, compliance to ICH-GCP and other regulatory norms, an ethically sound patient recruitment strategy, and efficient site management.

 

QUICK LINKS          
 
CRP Course I5 Site List
Scheldule Y CDSCO Website
GCP E6 Guideline FDA Guidance
 

 

LATEST NEWS
  • CDSCO issues diretion to Zonal Offices for conduction inspection of clinical trial site
  • Clinical trial industry is no killing machine: G.N. Singh - Livemint
  • Draft Guideline of FDA on Electronic Source Capturing
  • ICH makes progress on ongoing reforms and adopts Guidelines for safety reporting. Press Release - ICH Steering Committee, San Diego, California, USA, November 2012
  • DCGI initiates surprise inspection drive on CROs across India
  • Recent draft guidelines release by DCGI for public review and opinion
  • I5 Clinical Research launches FREE GCP Accreditation Test (GAT) for Clinical Research Professionals
  • I5 Clinical Research launches Clinical Research Professional (CRP) Course
  • INC Research to acquire Kendle International
  • Nautic purchase of Omnicare Clinical Research part of recent acquisition trend of mid-sized CROs
NEWS & EVENTS
 
I5 launched it new division I5 Health Care

I5 launched its new division named I5 Health care as A unit of I5 Clinical Research Pvt Ltd in this new financial year 2014.

With a deep experience and versatile divisions in research and health care sector, I5 had developed a commendable network in the health care market with respect to Doctors, Hospitals and Pharmaceutical Companies. Also, I5 has more than 25 exclusive hospitals which are working under the management of I5 as far as Clinical Operations is concerned. Considering these facts, it was found to be a convincing decision for I5 to launch its new division named “I5 Health Care”, to deal with Drug trading which includes drug Manufacturing, distribution and Marketing.

I5 health care will be initially functioning in Tamil Nadu, Karnataka and Gujarat and will launch its operation in Maharashtra and Rajasthan by 2015, with this new division I5 is expected to double its annual turnover by the financial year end and committed to become a key Production and Distribution company in generic market in next three years.

The details about the Health Care division and its product range are available here.

 
 

MORE NEWS...

I5 launched it new division I5 Health Care
Updated: 20th May 2014

CDSCO issues diretion to Zonal Offices for conduction inspection of clinical trial site
Updated: 26th Mar 2013

Clinical trial industry is no killing machine: G.N. Singh - Livemint
Updated: 20th Mar 2013

Draft Guideline of FDA on Electronic Source Capturing
Updated: 1st Dec 2012

ICH makes progress on ongoing reforms and adopts Guidelines for safety reporting.

DCGI initiates surprise inspection drive on CROs across India

DCGI had released a new Ethics Notice on 16 Aug 12, which contains a check list of Essential elements that are to be included in the ICF.

Recent draft guidelines release by DCGI for public review and opinion

I5 Clinical Research launches FREE GCP Accreditation Test (GAT) for Clinical Research Professionals

I5 Clinical Research launches Clinical Research Professional (CRP) Course

INC Research to acquire Kendle International

Nautic purchase of Omnicare Clinical Research part of recent acquisition trend of mid-sized CROs

Bayer And Regeneron Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion

FDA to amend trial investigator disqualification regulations

Clinical trial sites need a proactive compliance strategy

 

 

 
Home  |  Contact Us © 2011. All rights reserved. I5 Clinical Research Pvt Ltd.  Terms & Conditions  |  Privacy Policy